215 related articles for article (PubMed ID: 34316033)
1. Cytokine-enhanced cytolytic activity of exosomes from NK Cells.
Enomoto Y; Li P; Jenkins LM; Anastasakis D; Lyons GC; Hafner M; Leonard WJ
Cancer Gene Ther; 2022 Jun; 29(6):734-749. PubMed ID: 34316033
[TBL] [Abstract][Full Text] [Related]
2. Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18.
Aarsund M; Segers FM; Wu Y; Inngjerdingen M
Cancer Immunol Immunother; 2022 Sep; 71(9):2227-2238. PubMed ID: 35119498
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins.
Aarsund M; Nyman TA; Stensland ME; Wu Y; Inngjerdingen M
Front Immunol; 2022; 13():977353. PubMed ID: 36189227
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
[TBL] [Abstract][Full Text] [Related]
5. Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells.
Li Q; Huang Q; Huyan T; Wang Y; Huang Q; Shi J
Exp Cell Res; 2018 Feb; 363(2):141-150. PubMed ID: 29269076
[TBL] [Abstract][Full Text] [Related]
6. Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors.
Federici C; Shahaj E; Cecchetti S; Camerini S; Casella M; Iessi E; Camisaschi C; Paolino G; Calvieri S; Ferro S; Cova A; Squarcina P; Bertuccini L; Iosi F; Huber V; Lugini L
Front Immunol; 2020; 11():262. PubMed ID: 32231660
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells.
Wu CH; Li J; Li L; Sun J; Fabbri M; Wayne AS; Seeger RC; Jong AY
J Extracell Vesicles; 2019; 8(1):1588538. PubMed ID: 30891164
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
Pintaric M; Gerner W; Saalmüller A
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
[TBL] [Abstract][Full Text] [Related]
9. NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy.
Lu YC; Ho CH; Hong JH; Kuo MC; Liao YA; Jaw FS; Cheng JC; Huang CY; Chang KP; Chen CH; Lin JA; Hsiao A; Kung HN
Mol Oncol; 2023 Aug; 17(8):1613-1627. PubMed ID: 36931723
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.
Matchett EC; Kornbluth J
Front Immunol; 2023; 14():1265101. PubMed ID: 37818374
[TBL] [Abstract][Full Text] [Related]
11. A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
St-Denis-Bissonnette F; Cummings SE; Qiu S; Stalker A; Muradia G; Mehic J; Mediratta K; Kaczmarek S; Burger D; Lee SH; Wang L; Lavoie JR
J Extracell Vesicles; 2023 Dec; 12(12):e12387. PubMed ID: 38054534
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
Front Immunol; 2021; 12():658698. PubMed ID: 34093547
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
[TBL] [Abstract][Full Text] [Related]
15. Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.
Gorvel L; Korenfeld D; Tung T; Klechevsky E
J Immunol; 2017 Aug; 199(4):1290-1300. PubMed ID: 28701509
[TBL] [Abstract][Full Text] [Related]
16. Alcohol consumption decreases IL-2-induced NF-kappaB activity in enriched NK cells from C57BL/6 mice.
Zhou J; Meadows GG
Toxicol Sci; 2003 May; 73(1):72-9. PubMed ID: 12700414
[TBL] [Abstract][Full Text] [Related]
17. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
18. Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different?
Lettau M; Janssen O
Front Immunol; 2021; 12():804895. PubMed ID: 35003134
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
[TBL] [Abstract][Full Text] [Related]
20. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
